Strategically targeting MYC in cancer [version 1; referees: 2 approved]

by Valeriya Posternak, Michael D. Cole
Published 2016-03-01

Drug facilitated sexual assault: detection and stability of benzodiazepines in spiked drinks using gas chromatography-mass spectrometry.

by Lata Gautam, Sarah D Sharratt, Michael D Cole
Published 2014-01-01

Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex.

by Edmond J Feris, John W Hinds, Michael D Cole
Published 2019-01-01

Retroviruses hijack chromatin loops to drive oncogene expression and highlight the chromatin architecture around proto-oncogenic loci.

by Jillian M Pattison, Jason B Wright, Michael D Cole
Published 2015-01-01

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

by Mauro Savino, Daniela Annibali, Nicoletta Carucci, Emilia Favuzzi, Michael D Cole, Gerard I Evan, Laura Soucek, Sergio Nasi
Published 2011-01-01

A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.

by Sanjay Chandriani, Eirik Frengen, Victoria H Cowling, Sarah A Pendergrass, Charles M Perou, Michael L Whitfield, Michael D Cole
Published 2009-08-01

Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples

by Ivan P. Gorlov, Claudio W. Pikielny, Hildreth R. Frost, Stephanie C. Her, Michael D. Cole, Samuel D. Strohbehn, David Wallace-Bradley, Marek Kimmel, Olga Y. Gorlova, Christopher I. Amos
Published 2018-11-01